A further analysis of the clinical characteristics of TET2-mutated versus -unmutated ET patients revealed the older age of ET patients with TET2 mutations, consistent with the results obtained by Tefferi et al. [38] and Brousseau et al. [39]. The gene discussed is TET2; the disease is essential thrombocythemia.